Rankings / Metabolic Health

Naltrexone (low dose, LDN)

Metabolic Health · Opioid antagonist

Tier C+

opioidprescription
5.3 / 10
Tier C+
Ev 3 Bn 2 Sf 9

Bottom line

Read Off Label grades Naltrexone (low dose, LDN) as C+ (5.3/10) based on weak evidence, low benefit magnitude, and a low-risk safety profile.

Not really a weight loss drug in isolation; part of Contrave combo.

Typical use: 1. — Rx.

What this is

Not really a weight loss drug in isolation; part of Contrave combo. LDN has legitimate off-label uses for fibromyalgia and autoimmune conditions but weight loss claims are thin. Widely used in biohacker/alt-med circles.

Mechanism

At low doses (1.5-4.5 mg): transient mu-opioid blockade triggers rebound endorphin release; modulates immune/microglial function; TLR4 antagonism

Dose & route

1.5-4.5 mg PO at bedtime

Common questions

Does Naltrexone (low dose, LDN) work?
Read Off Label rates the evidence for Naltrexone (low dose, LDN) as Weak and the benefit magnitude as low, producing an overall grade of C+ (5.3/10). Not really a weight loss drug in isolation; part of Contrave combo.
Is Naltrexone (low dose, LDN) safe?
Naltrexone (low dose, LDN) has a low risk profile in published human data. Legal status: Rx (off-label; compounded). This is not medical advice — see the disclaimer.
What is the typical dose for Naltrexone (low dose, LDN)?
1.5-4.5 mg PO at bedtime
How does Naltrexone (low dose, LDN) work?
At low doses (1.5-4.5 mg): transient mu-opioid blockade triggers rebound endorphin release; modulates immune/microglial function; TLR4 antagonism

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.